BaxHTN – Efficacy and safety of the aldosterone synthase inhibitor baxdrostat in patients with uncontrolled or resistant hypertension
30 August 2025 (16:15 - 16:25)
Organised by: 
About the speaker
University College London, London (United Kingdom of Great Britain & Northern Ireland)
11 More presentations in this session
Access the full session
The Event
ESC Congress 2025
30 August 2025
16:15 CET
You may be interested in
Congress Session
29 August 2025
Congress Presentation
2 September 2024
Congress Session
30 August 2025
